Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2006 | 03-2006 | |
Operating Expenses | 2,225 | 1,325 |
Operating Income | -2,225 | -1,325 |
Interest Expense | 38 | 21 |
Other Income | 6 | 2 |
Pre-tax Income | -2,257 | -1,344 |
Income Tax | 11 | N/A |
Net Income Continuous | -2,268 | -1,344 |
Net Income | $-2,268 | $-1,344 |
EPS Basic Total Ops | -37.24 | -30.03 |
EPS Basic Continuous Ops | -36.95 | -30.13 |
EPS Diluted Total Ops | -37.24 | -30.03 |
EPS Diluted Continuous Ops | -36.95 | -30.13 |
EBITDA(a) | $-2,165 | $-1,208 |